1-Isopropylazetidin-3-ol hydrochloride, 95.0%, 10g

4-(1H-1,2,4-Triazol-1-yl)benzoic acid, 95.0%, 10g

Sample beakers ROTILABO®, 50 ml, 100 Piece(s)

7,7-Dimethyl-2,6-dioxa-9-azaspiro[4.5]decane, 95%, 250mg

2-Phenyl-1-(2-thioxothiazolidin-3-yl)ethan-1-one, 95%, 250mg

GC capillary column ROTI®Cap-5 MS Ultra, 60 m, 0.25 mm, 1.00 µm, 1 Piece(s)

3-(1-((Benzyloxy)carbonyl)piperidin-4-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 250mg

Diisobutyl Disulfide>98.0%(GC)5mL

(6R)-3-[(2-chlorophenyl)sulfanyl]-6-[4-(morpholin-4-yl)phenyl]-6-(thiophen-3-yl)piperidine-2,4-dione, 98%, 5mg

2,2-Difluoro-2-(1-methyl-1H-imidazol-2-yl)acetic acid, lithium salt, 5g

(4-(N-Methylsulfamoyl)phenyl)boronic acid, 97.0%, 1g

4,4'-(Buta-1,3-diyne-1,4-diyl)dibenzaldehyde, 98%, 250mg

2-Cyclohexyl-2-methylpropanoic acid, 98%, 250mg